The Javelin aims to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD). Shockwave said its novel, non-balloon IVL platform delivers a similar safety and efficacy profile to its legacy catheters, bolstering its market-leading IVL portfolio.

Santa Clara, California-based Shockwave designed Javelin with a single 120-pulse lithotripsy emitter at the distal tip of the catheter. The company developed it for use in sub-total occlusions or extremely narrowed vessels. These are vessels in which a wire can cross but devices can not. With this new platform, the sonic pressure waves expand spherically from the forward-shifted emitter beyond the tip of the catheter. It allows modification of the obstructive calcification that facilitates device crossing.